Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent depression updates: relevant presentations.

David S Janowsky1

  • 1Department of Psychiatry, CB# 7175, University of North Carolina School of Medicine, Chapel Hill, NC 27599-7175, USA. David_Janowsky@med.unc.edu

Current Psychiatry Reports
|November 11, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Changes in Expression of DNA-Methyltransferase and Cannabinoid Receptor mRNAs in Blood Lymphocytes After Acute Cannabis Smoking.

Frontiers in psychiatry·2022
Same author

Interpersonal Maneuvers of Manic Patients.

Focus (American Psychiatric Publishing)·2020
Same author

Cholinergic regulation of mood: from basic and clinical studies to emerging therapeutics.

Molecular psychiatry·2018
Same author

The catecholaminergic-cholinergic balance hypothesis of bipolar disorder revisited.

European journal of pharmacology·2014
Same author

Lithium-induced renal insufficiency: a longitudinal study of creatinine increases in intellectually disabled adults.

Journal of clinical psychopharmacology·2011
Same author

Serendipity strikes again: scopolamine as an antidepressant agent in bipolar depressed patients.

Current psychiatry reports·2011

This review covers novel psychopharmacologic treatments for major depressive disorder and predictors of efficacy. It also explores the hypothalamic-pituitary-adrenal axis activation in depression.

Area of Science:

  • Neuropsychopharmacology
  • Psychiatry

Background:

  • Review of key findings from the 2005 American College of Neuropsychopharmacology and 2006 Collegium Internationale Neuro-Psychopharmacologicum meetings.
  • Focus on depression-relevant research presented at these major scientific gatherings.

Framework:

  • Discussion of novel psychopharmacologic interventions for major depressive disorder.
  • Exploration of factors predicting treatment efficacy.

Implementation:

  • Analysis of research abstracts detailing new therapeutic approaches.
  • Synthesis of data on patient response to various treatments.

Implications:

  • Provides insights into current and emerging treatments for major depressive disorder.

Related Experiment Videos

  • Contributes to understanding the neurobiological underpinnings of depression, particularly HPA axis function.